Dawen Sui

2.7k total citations
46 papers, 1.6k citations indexed

About

Dawen Sui is a scholar working on Oncology, Epidemiology and Immunology. According to data from OpenAlex, Dawen Sui has authored 46 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Oncology, 9 papers in Epidemiology and 8 papers in Immunology. Recurrent topics in Dawen Sui's work include Cancer Immunotherapy and Biomarkers (9 papers), Cutaneous lymphoproliferative disorders research (6 papers) and Immunotherapy and Immune Responses (5 papers). Dawen Sui is often cited by papers focused on Cancer Immunotherapy and Biomarkers (9 papers), Cutaneous lymphoproliferative disorders research (6 papers) and Immunotherapy and Immune Responses (5 papers). Dawen Sui collaborates with scholars based in United States, China and Canada. Dawen Sui's co-authors include Leslie R. Schover, Leah Neese, Andrea L. Canada, Madeleine Duvic, Rakhshandra Talpur, Pamela Gangar, Rosell Jenkins, Michael T. Tetzlaff, Audra L. Clos and Janice Ritch and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Advanced Functional Materials.

In The Last Decade

Dawen Sui

45 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dawen Sui United States 22 588 296 284 260 222 46 1.6k
Stacie Hudgens United States 22 535 0.9× 71 0.2× 217 0.8× 184 0.7× 181 0.8× 104 1.7k
Christos Christodoulou Greece 25 1.1k 1.9× 180 0.6× 124 0.4× 193 0.7× 102 0.5× 103 2.1k
Shigeru Imoto Japan 31 1.1k 1.9× 193 0.7× 255 0.9× 759 2.9× 132 0.6× 114 2.7k
Aike A. Kruize Netherlands 25 276 0.5× 118 0.4× 95 0.3× 266 1.0× 98 0.4× 85 2.3k
Irene Halperín Spain 29 230 0.4× 116 0.4× 223 0.8× 160 0.6× 392 1.8× 128 2.8k
Anna Lee United States 24 445 0.8× 198 0.7× 38 0.1× 166 0.6× 264 1.2× 143 2.0k
Koen De Geest United States 22 693 1.2× 126 0.4× 49 0.2× 127 0.5× 316 1.4× 44 2.3k
Alan R. Berger Canada 27 215 0.4× 125 0.4× 86 0.3× 106 0.4× 297 1.3× 93 2.8k
A Bartolucci United States 21 288 0.5× 164 0.6× 43 0.2× 172 0.7× 128 0.6× 45 1.3k
Samira Zeynalova Germany 23 772 1.3× 94 0.3× 94 0.3× 1.5k 5.8× 81 0.4× 79 2.2k

Countries citing papers authored by Dawen Sui

Since Specialization
Citations

This map shows the geographic impact of Dawen Sui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dawen Sui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dawen Sui more than expected).

Fields of papers citing papers by Dawen Sui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dawen Sui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dawen Sui. The network helps show where Dawen Sui may publish in the future.

Co-authorship network of co-authors of Dawen Sui

This figure shows the co-authorship network connecting the top 25 collaborators of Dawen Sui. A scholar is included among the top collaborators of Dawen Sui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dawen Sui. Dawen Sui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Altan, Mehmet, Dawen Sui, Cai Xu, et al.. (2025). PD-L1 Testing, Treatment Patterns, and Clinical Outcomes Among Patients with Metastatic NSCLC at an Academic Medical Center, 2017–2021. PubMed. 8(2). 161–171. 1 indexed citations
2.
3.
Sui, Dawen, et al.. (2023). Surgeons of the Future: A Novel Screening Tool for High-School Students. Journal of Surgical Research. 290. 61–70. 2 indexed citations
4.
Wang, Yuling, Vijaya Ramachandran, Dawen Sui, et al.. (2021). Evaluation of Plasma IL-6 in Patients with Melanoma as a Prognostic and Checkpoint Immunotherapy Predictive Biomarker. Journal of Investigative Dermatology. 142(7). 2046–2049.e3. 16 indexed citations
5.
Huang, Xiao, Qingqing Ding, Hua Guo, et al.. (2020). Comparison of three FDA-approved diagnostic immunohistochemistry assays of PD-L1 in triple-negative breast carcinoma. Human Pathology. 108. 42–50. 25 indexed citations
6.
Feng, Runhua, Yuling Wang, Vijaya Ramachandran, et al.. (2020). Characterization of novel neutralizing mouse monoclonal antibody JM1-24-3 developed against MUC18 in metastatic melanoma. Journal of Experimental & Clinical Cancer Research. 39(1). 273–273. 6 indexed citations
7.
Fang, Shenying, Momiao Xiong, Yuling Wang, et al.. (2019). Role of Immune Response, Inflammation, and Tumor Immune Response–Related Cytokines/Chemokines in Melanoma Progression. Journal of Investigative Dermatology. 139(11). 2352–2358.e3. 25 indexed citations
8.
Aung, Phyu P., Edwin R. Parra, Souptik Barua, et al.. (2019). B7-H3 Expression in Merkel Cell Carcinoma–Associated Endothelial Cells Correlates with Locally Aggressive Primary Tumor Features and Increased Vascular Density. Clinical Cancer Research. 25(11). 3455–3467. 29 indexed citations
9.
Loghavi, Sanam, Dawen Sui, Peng Wei, et al.. (2018). Validation of the 2017 revision of the WHO chronic myelomonocytic leukemia categories. Blood Advances. 2(15). 1807–1816. 29 indexed citations
10.
Talpur, Rakhshandra, Dawen Sui, Pamela Gangar, Bouthaina S. Dabaja, & Madeleine Duvic. (2015). Retrospective Analysis of Prognostic Factors in 187 Cases of Transformed Mycosis Fungoides. Clinical Lymphoma Myeloma & Leukemia. 16(1). 49–56. 38 indexed citations
11.
Fang, Shenying, Yuling Wang, Yun Shin Chun, et al.. (2015). Association of Common Genetic Polymorphisms with Melanoma Patient IL-12p40 Blood Levels, Risk, and Outcomes. Journal of Investigative Dermatology. 135(9). 2266–2272. 5 indexed citations
12.
Fang, Shenying, Yuling Wang, Yun Shin Chun, et al.. (2014). The relationship between blood IL‐12p40 level and melanoma progression. International Journal of Cancer. 136(8). 1874–1880. 4 indexed citations
13.
Ren, Xiaohui, Haihui Jiang, Xiaona Cui, et al.. (2013). Co-polysomy of chromosome 1q and 19p predicts worse prognosis in 1p/19q codeleted oligodendroglial tumors: FISH analysis of 148 consecutive cases. Neuro-Oncology. 15(9). 1244–1250. 16 indexed citations
14.
Huyghe, É., et al.. (2008). Banking on Fatherhood: pilot studies of a computerized educational tool on sperm banking before cancer treatment. Psycho-Oncology. 18(9). 1011–1014. 25 indexed citations
15.
Basen‐Engquist, Karen, Rachel T. Fouladi, Scott B. Cantor, et al.. (2007). Patient assessment of tests to detect cervical cancer. International Journal of Technology Assessment in Health Care. 23(2). 240–247. 14 indexed citations
16.
Canada, Andrea L., Leah Neese, Dawen Sui, & Leslie R. Schover. (2005). Pilot intervention to enhance sexual rehabilitation for couples after treatment for localized prostate carcinoma. Cancer. 104(12). 2689–2700. 164 indexed citations
17.
Wetter, David W., et al.. (2004). Late relapse/sustained abstinence among former smokers: a longitudinal study. Preventive Medicine. 39(6). 1156–1163. 84 indexed citations
18.
Duvic, Madeleine, Xiao Ni, Claudia Schulz, et al.. (2003). Tazarotene-Induced Gene 3 Is Suppressed in Basal Cell Carcinomas and Reversed In Vivo by Tazarotene Application. Journal of Investigative Dermatology. 121(4). 902–909. 32 indexed citations
19.
Velligan, Dawn I., Thomas J. Prihoda, Dawen Sui, et al.. (2003). The Effectiveness of Quetiapine Versus Conventional Antipsychotics in Improving Cognitive and Functional Outcomes in Standard Treatment Settings. The Journal of Clinical Psychiatry. 64(5). 524–531. 66 indexed citations
20.
Velligan, Dawn I., et al.. (2002). Frontal Systems Behavior Scale in schizophrenia: relationships with psychiatric symptomatology, cognition and adaptive function. Psychiatry Research. 113(3). 227–236. 91 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Stacie Hudgens Breakdown of academic impact, for papers by Christos Christodoulou Breakdown of academic impact, for papers by Shigeru Imoto Breakdown of academic impact, for papers by Aike A. Kruize Breakdown of academic impact, for papers by Irene Halperín Breakdown of academic impact, for papers by Anna Lee Breakdown of academic impact, for papers by Koen De Geest Breakdown of academic impact, for papers by Alan R. Berger Breakdown of academic impact, for papers by A Bartolucci Breakdown of academic impact, for papers by Samira Zeynalova
Rankless by CCL
2026